evaluation of the ability of a drug (Tranexamic acid) in reducing blood loss during and after surgery in head and neck cancer patients
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Head and neck cancer patients
- Registration Number
- CTRI/2018/05/014184
- Lead Sponsor
- AIIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 86
Inclusion Criteria
BMI 18.5 to 29.99 kg/sq.m
ASA 1 to 3
Exclusion Criteria
Patients refusal
emergency surgery
jail inmates,HIV patients, pregnant woman
preoperative haemoglobin less than 7 gm % or greater than 16 gm%
known case of coagulopathy, patients on anti coagulation therapy
contraindications to tranexamic acid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method